YF-VAX 1 dose vials
Ended Awarded Last action
- Contract number
- SPE2DR26FRAP0
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,368
Award facts
- Contract value 100% obligated
- $16,368.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $16,368.04 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) dose vials. The delivery order, issued on December 31, 2025, with an ultimate completion date of January 23, 2026, carries no set-aside designation, indicating the vendor competed in unrestricted federal procurement. DMS Pharmaceutical Group is the sole contractor on this award with no identified subcontractors.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical and medical supply support to Department of Defense military healthcare facilities worldwide. The parent IDC, designated SPE2DR and valued at $499,999,999, was awarded on November 13, 2025, and establishes DMS Pharmaceutical Group as one of multiple regional prime vendor contractors through December 31, 2036. The company's established performance across numerous delivery orders for diverse pharmaceutical products, including branded and generic medications, biologics, vaccines, and specialty pharmaceuticals, demonstrates its capability to fulfill the specialized medical supply requirements of the federal military healthcare system.
Quick answers
Who was awarded contract SPE2DR26FRAP0?
SPE2DR26FRAP0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 31, 2025.
How much is contract SPE2DR26FRAP0 worth?
The government has obligated $16,368 on SPE2DR26FRAP0.
Is contract SPE2DR26FRAP0 an order under another contract?
Yes. SPE2DR26FRAP0 is a delivery order under SPE2DR25D9104, an indefinite delivery contract.
Was contract SPE2DR26FRAP0 competed?
The extent of competition for SPE2DR26FRAP0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award